| Lizenz: Creative Commons Namensnennung 4.0 International PDF - Veröffentlichte Version (998kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-448130
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.44813
Hähnel, Viola ; Peterhoff, David 
; Bäuerlein, Veronika ; Brosig, Andreas-Michael ; Palmer, Irene ; Johnson, Christian ; Bica, Adelina ; Totir, Monica ; Ossner, Thomas ; Stemmer, Barbara ; Toelge, Martina ; Schütz, Anja ; Niller, Hans-Helmut ; Schmidt, Barbara ; Wagner, Ralf ; Gessner, Andre ; Burkhardt, Ralph ; Offner, Robert
; Bäuerlein, Veronika ; Brosig, Andreas-Michael ; Palmer, Irene ; Johnson, Christian ; Bica, Adelina ; Totir, Monica ; Ossner, Thomas ; Stemmer, Barbara ; Toelge, Martina ; Schütz, Anja ; Niller, Hans-Helmut ; Schmidt, Barbara ; Wagner, Ralf ; Gessner, Andre ; Burkhardt, Ralph ; Offner, Robert 
Zusammenfassung
The ongoing coronavirus disease 2019 (COVID-19) pandemic emerged in December 2019. Convalescent plasma represents a promising COVID-19 treatment. Here, we report on the manufacturing of a plasma-based product containing antibodies specific to SARS-CoV-2 obtained from recently recovered COVID-19 patients. Convalescent plasma donors were screened as follows: 1) previously confirmed SARS-CoV-2 ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags
Downloadstatistik